← Back to headlines
J&J Pauses Enrollment in Mid-Stage Alzheimer's Drug Trial
AC Immune announced that its partner Johnson & Johnson has paused enrollment in a mid-stage clinical trial for an Alzheimer’s drug.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
